Hege S Haugnes

Summary

Publications

  1. ncbi request reprint Seminoma patients treated at a minor oncological department during 1986-2010: treatment and outcome
    Hege S Haugnes
    Department of Oncology, University Hospital of North Norway, Tromsø, Norway Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    Anticancer Res 34:4253-60. 2014
  2. doi request reprint Assessment of late urinary, bowel and sexual function after dose escalation from 70 to 76 Gy using image-guided radiotherapy in curative treatment of prostate cancer
    Hege S Haugnes
    Department of Oncology, University Hospital of North Norway, Tromsø, Norway
    Scand J Urol Nephrol 46:124-32. 2012
  3. doi request reprint Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
    Hege S Haugnes
    Oncology Department, University Hospital of North Norway, Tromsø, Norway
    J Clin Oncol 30:3752-63. 2012
  4. ncbi request reprint High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)
    Hege S Haugnes
    Department of Oncology, University Hospital of North Norway, Tromsø, Norway
    Acta Oncol 51:168-76. 2012
  5. doi request reprint Pulmonary function in long-term survivors of testicular cancer
    Hege S Haugnes
    Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø N 9037, Norway
    J Clin Oncol 27:2779-86. 2009
  6. doi request reprint Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
    Hege S Haugnes
    Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    J Clin Oncol 28:4649-57. 2010
  7. ncbi request reprint Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors
    Mette Sprauten
    Mette Sprauten, Milada Cvancarova, Sophie D Fosså, and Jan Oldenburg, Oslo University Hospital Trine Bjøro, Oslo University Hospital and University of Oslo Johan Bjerner, Fürst Medical Laboratory, Oslo Marianne Brydøy, University of Bergen, Bergen and Hege S Haugnes, University of Tromsø and University Hospital of North Norway, Tromsø, Norway
    J Clin Oncol 32:571-8. 2014

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Seminoma patients treated at a minor oncological department during 1986-2010: treatment and outcome
    Hege S Haugnes
    Department of Oncology, University Hospital of North Norway, Tromsø, Norway Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    Anticancer Res 34:4253-60. 2014
    ..To present results for patients with seminoma treated at our University Clinic...
  2. doi request reprint Assessment of late urinary, bowel and sexual function after dose escalation from 70 to 76 Gy using image-guided radiotherapy in curative treatment of prostate cancer
    Hege S Haugnes
    Department of Oncology, University Hospital of North Norway, Tromsø, Norway
    Scand J Urol Nephrol 46:124-32. 2012
    ....
  3. doi request reprint Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
    Hege S Haugnes
    Oncology Department, University Hospital of North Norway, Tromsø, Norway
    J Clin Oncol 30:3752-63. 2012
    ..Moreover, we postulate recommendations for general medical evaluations that should begin after treatment is completed and continue during follow-up...
  4. ncbi request reprint High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)
    Hege S Haugnes
    Department of Oncology, University Hospital of North Norway, Tromsø, Norway
    Acta Oncol 51:168-76. 2012
    ..The aim of this study was to present survival and toxicity data for patients treated with high-dose chemotherapy (HDCT) within the SWENOTECA IV cancer care program...
  5. doi request reprint Pulmonary function in long-term survivors of testicular cancer
    Hege S Haugnes
    Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø N 9037, Norway
    J Clin Oncol 27:2779-86. 2009
    ..Long-term toxicity after cancer treatment has gained increasing clinical attention. We evaluated pulmonary function in long-term survivors of testicular cancer (TC)...
  6. doi request reprint Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
    Hege S Haugnes
    Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    J Clin Oncol 28:4649-57. 2010
    ..To evaluate the prevalence of cardiovascular risk factors and long-term incidence of cardiovascular disease (CVD) in survivors of testicular cancer (TC)...
  7. ncbi request reprint Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors
    Mette Sprauten
    Mette Sprauten, Milada Cvancarova, Sophie D Fosså, and Jan Oldenburg, Oslo University Hospital Trine Bjøro, Oslo University Hospital and University of Oslo Johan Bjerner, Fürst Medical Laboratory, Oslo Marianne Brydøy, University of Bergen, Bergen and Hege S Haugnes, University of Tromsø and University Hospital of North Norway, Tromsø, Norway
    J Clin Oncol 32:571-8. 2014
    ..To assess longitudinal long-term alterations of testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in testicular cancer survivors (TCSs)...